Skip to Content

Lords and Company Worldwide Holdings Corp LRDS

Morningstar Rating
CAD 0.02 0.01 (20.00%)
View Full Chart
Unlock our analysis with Morningstar Investor

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

LRDS is trading at a 512% premium.
Price
CAD 0.02
Fair Value
CAD 2.84
Uncertainty
Extreme
1-Star Price
CAD 9.19
5-Star Price
CAD 6.50
Economic Moat
Zcfgsn
Capital Allocation
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if LRDS is a good fit for your portfolio.

Trading Information

Previous Close Price
CAD 0.03
Day Range
CAD 0.020.02
52-Week Range
CAD 0.020.02
Bid/Ask
CAD 0.00 / CAD 0.00
Market Cap
CAD 1.03 Mil
Volume/Avg
26,000 / 0

Key Statistics

Price/Earnings (Normalized)
Price/Sales
0.15
Dividend Yield (Trailing)
Dividend Yield (Forward)
Total Yield

Company Profile

Lords and Company Worldwide Holdings Corp is lifestyle-inspired health, wellness, and clothing brand. The company through its Lords brand develops, produces and markets lifestyle apparel and natural health products through its E-commerce platform to its customers. Along with apparels the company is also dedicated to selling premium oil, medical wellness solutions, vape cartridges, pens, tinctures and capsules, edibles, and topicals to service the exploding CBD-infused products industry. The company has one reportable segment that is sale of dietary supplement and health and wellness products in the United States.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees

Valuation

Metric
LRDS
Price/Earnings (Normalized)
Price/Book Value
Price/Sales
0.15
Price/Cash Flow
Price/Earnings
No chart available

Financial Strength

Metric
LRDS
Quick Ratio
0.12
Current Ratio
0.20
Interest Coverage
−1,010.33
Quick Ratio
LRDS

Profitability

Metric
LRDS
Return on Assets (Normalized)
−90.59%
Return on Equity (Normalized)
Return on Invested Capital (Normalized)
−446.03%
Return on Assets
LRDS
See how this stock stacks up to its competitors with Morningstar Investor

Drug Manufacturers - Specialty & Generic Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Merck KGaA ADR
MKKGY
VfklswsnLmjlf$80.3 Bil
Zoetis Inc Class A
ZTS
YwwvbdddkNtx$77.8 Bil
Haleon PLC ADR
HLN
CstdnrglZrtd$37.8 Bil
Dr Reddy's Laboratories Ltd ADR
RDY
GfjtwdmpZrbf$12.1 Bil
Viatris Inc
VTRS
TmbtylpgRjps$12.1 Bil
Catalent Inc
CTLT
BxdslzrjZtcqsx$10.0 Bil
Perrigo Co PLC
PRGO
BxmdvccNljcg$3.7 Bil
Prestige Consumer Healthcare Inc
PBH
TtxgfkyfBstqtn$3.2 Bil
Curaleaf Holdings Inc
CURLF
YplxkvjgBjdh$3.0 Bil
Green Thumb Industries Inc
GTBIF
BdnmtgwqTyzk$2.7 Bil

Sponsor Center